154 related articles for article (PubMed ID: 30342872)
21. Prediction of hepatocellular carcinoma development by aminotransferase to platelet ratio index in primary biliary cholangitis.
Cheung KS; Seto WK; Fung J; Mak LY; Lai CL; Yuen MF
World J Gastroenterol; 2017 Nov; 23(44):7863-7874. PubMed ID: 29209127
[TBL] [Abstract][Full Text] [Related]
22. The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection.
Abu-Amara M; Cerocchi O; Malhi G; Sharma S; Yim C; Shah H; Wong DK; Janssen HL; Feld JJ
Gut; 2016 Aug; 65(8):1347-58. PubMed ID: 25934760
[TBL] [Abstract][Full Text] [Related]
23. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.
Lai MS; Hsieh MS; Chiu YH; Chen TH
Hepatology; 2006 Jun; 43(6):1295-302. PubMed ID: 16729295
[TBL] [Abstract][Full Text] [Related]
24. Risks of hepatocellular carcinoma and cirrhosis-associated complications in patients with rheumatoid arthritis: a 10-year population-based cohort study in Taiwan.
Hsu CS; Lang HC; Huang KY; Chao YC; Chen CL
Hepatol Int; 2018 Nov; 12(6):531-543. PubMed ID: 30426396
[TBL] [Abstract][Full Text] [Related]
25. Risk of hepatocellular carcinoma in individuals without traditional risk factors: development and validation of a novel risk score.
Sinn DH; Kang D; Cho SJ; Paik SW; Guallar E; Cho J; Gwak GY
Int J Epidemiol; 2020 Oct; 49(5):1562-1571. PubMed ID: 32725117
[TBL] [Abstract][Full Text] [Related]
26. Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study.
Huang YW; Wang TC; Yang SS; Lin SY; Fu SC; Hu JT; Liu CJ; Kao JH; Chen DS
Aliment Pharmacol Ther; 2015 Oct; 42(7):902-11. PubMed ID: 26211742
[TBL] [Abstract][Full Text] [Related]
27. Type 2 diabetes and hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.
Li Q; Li WW; Yang X; Fan WB; Yu JH; Xie SS; Liu L; Ma LX; Chen SJ; Kato N
Int J Cancer; 2012 Sep; 131(5):1197-202. PubMed ID: 22052244
[TBL] [Abstract][Full Text] [Related]
28. Non-invasive risk scores do not reliably identify future cirrhosis or hepatocellular carcinoma in Type 2 diabetes: The Edinburgh type 2 diabetes study.
Grecian SM; McLachlan S; Fallowfield JA; Kearns PKA; Hayes PC; Guha NI; Morling JR; Glancy S; Williamson RM; Reynolds RM; Frier BM; Zammitt NN; Price JF; Strachan MWJ
Liver Int; 2020 Sep; 40(9):2252-2262. PubMed ID: 32638496
[TBL] [Abstract][Full Text] [Related]
29. Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment.
Wong GL; Chan HL; Chan HY; Tse PC; Tse YK; Mak CW; Lee SK; Ip ZM; Lam AT; Iu HW; Leung JM; Wong VW
Gastroenterology; 2013 May; 144(5):933-44. PubMed ID: 23415803
[TBL] [Abstract][Full Text] [Related]
30. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
[TBL] [Abstract][Full Text] [Related]
31. Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan.
Chen CT; Chen JY; Wang JH; Chang KC; Tseng PL; Kee KM; Chen PF; Tsai LS; Chen SC; Lin SC; Lu SN
Kaohsiung J Med Sci; 2013 Aug; 29(8):451-9. PubMed ID: 23906236
[TBL] [Abstract][Full Text] [Related]
32. Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir).
Ganne-Carrié N; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; de Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Benhamou Y; Pilette C; Silvain C; Christidis C; Capron D; Bernard-Chabert B; Zucman D; Di Martino V; Trinchet JC; Nahon P; Roudot-Thoraval F;
Hepatology; 2016 Oct; 64(4):1136-47. PubMed ID: 27348075
[TBL] [Abstract][Full Text] [Related]
33. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
34. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.
Kim GA; Lee HC; Kim MJ; Ha Y; Park EJ; An J; Lee D; Shim JH; Kim KM; Lim YS
J Hepatol; 2015 May; 62(5):1092-9. PubMed ID: 25445399
[TBL] [Abstract][Full Text] [Related]
35. The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease.
Lee TY; Wu JC; Yu SH; Lin JT; Wu MS; Wu CY
Int J Cancer; 2017 Oct; 141(7):1307-1314. PubMed ID: 28509327
[TBL] [Abstract][Full Text] [Related]
36. [Validation study of prediction models of hepatitis B virus-related hepatocellular carcinoma].
Chen W; Chen J; Zheng Q; Dong J; You J; Yuan P; Zhu Y; Liu YR; Jiang JJ
Zhonghua Gan Zang Bing Za Zhi; 2015 Jul; 23(7):507-11. PubMed ID: 26398841
[TBL] [Abstract][Full Text] [Related]
37. Liver volume-based prediction model stratifies risks for hepatocellular carcinoma in chronic hepatitis B patients on surveillance.
Lee CS; Jung YJ; Kim SS; Cheong JY; Lee GR; Kim HG; Kim BH; Chung JW; Jang ES; Jeong SH; Lee KH; Kim JW
PLoS One; 2018; 13(1):e0190261. PubMed ID: 29293612
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of a risk prediction model for chronic kidney disease among individuals with type 2 diabetes.
Lin CC; Niu MJ; Li CI; Liu CS; Lin CH; Yang SY; Li TC
Sci Rep; 2022 Mar; 12(1):4794. PubMed ID: 35314714
[TBL] [Abstract][Full Text] [Related]
39. Fine Particle Pollution, Alanine Transaminase, and Liver Cancer: A Taiwanese Prospective Cohort Study (REVEAL-HBV).
Pan WC; Wu CD; Chen MJ; Huang YT; Chen CJ; Su HJ; Yang HI
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26561636
[TBL] [Abstract][Full Text] [Related]
40. Association between complicated liver cirrhosis and the risk of hepatocellular carcinoma in Taiwan.
Hung TH; Liang CM; Hsu CN; Tai WC; Tsai KL; Ku MK; Wang JW; Tseng KL; Yuan LT; Nguang SH; Yang SC; Wu CK; Hsu PI; Wu DC; Chuah SK
PLoS One; 2017; 12(7):e0181858. PubMed ID: 28742130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
